Why is Shukra Pharma. falling/rising?

As of 02-Jul, Shukra Pharmaceuticals Ltd's stock price is currently at 15.80, reflecting an increase of 0.75 or 4.98%. The stock has been on an upward trend, gaining for the last four days and achieving a total return of 17.91% during this period. It has outperformed its sector by 4.9% today, and its delivery volume has surged by 514.43% compared to the five-day average, indicating rising investor participation. Despite the strong performance, the company faces challenges, including a significant decline in net sales and profits over the past year, which have fallen by 45.95% and 36.24%, respectively. Additionally, the stock is considered expensive with a high Price to Book Value ratio, and domestic mutual funds hold no stake in the company, suggesting a lack of confidence at current price levels.
In the broader market context, Shukra Pharmaceuticals has significantly outperformed the benchmark, with a one-week return of 17.21% compared to the Sensex's 0.79%, and a one-month return of 21.54% against the benchmark's 2.50%. This strong performance highlights the stock's resilience and appeal to investors despite the underlying financial challenges. The company's ability to service debt remains strong, with a low Debt to EBITDA ratio, and its operating profit has shown healthy long-term growth. However, the contrasting performance metrics and the absence of domestic mutual fund investment may indicate caution among institutional investors, which could impact future price movements.